A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism (Q35354770)

7 August 2017

title

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism (English)

1 reference

7 August 2017

0 references

0 references

8

David W Oslin

1 reference

7 August 2017

Helen Marie Pettinati

2

object named as

Helen M Pettinati

1 reference

7 August 2017

Kyle M Kampman

1

1 reference

7 August 2017

Kevin G Lynch

3

1 reference

7 August 2017

Tom Whittingham

4

1 reference

7 August 2017

Wayne Macfadden

5

1 reference

7 August 2017

Charles Dackis

6

1 reference

7 August 2017

Carlos Tirado

7

1 reference

7 August 2017

Thorne Sparkman

9

1 reference

7 August 2017

Charles P O'Brien

10

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Clinical Psychopharmacology

7 August 2017

published in

1 reference

7 August 2017

volume

27

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

344-351

1 reference

The status of disulfiram: a half of a century later

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Potential benefits of quetiapine in the treatment of substance dependence disorders

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Quetiapine for treatment of alcohol dependence.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

The assessment of anxiety states by rating

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Alcoholism and the dopaminergic system: a review

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Pharmacologic approaches to the management of alcoholism

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Effect of haloperidol on measures of craving and impaired control in alcoholic subjects

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Development of a Rating Scale for Primary Depressive Illness

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Ethanol enhances the release of dopamine and serotonin in the nucleus accumbens of HAD and LAD lines of rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

The Fifth Edition of the Addiction Severity Index

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Role of serotonin and serotonin-selective pharmacotherapy in alcohol dependence.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

The effect of olanzapine on craving and alcohol consumption

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

A double-blind, placebo-controlled study of olanzapine in the treatment of alcohol-dependence disorder

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

A multi-site study of alcohol subtypes: classification and overlap of unidimensional and multi-dimensional typologies

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Psychometric properties of the Penn Alcohol Craving Scale.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Seroquel: biochemical profile of a potential atypical antipsychotic

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3193934

Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype

26 September 2018

1 reference

12 December 2020

Prediction of 3-year outcome of treated alcoholics by an empirically derived multivariate typology

1 reference

12 December 2020

Multidimensional subtypes and treatment outcome in first-time DWI offenders

1 reference

12 December 2020

Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients

1 reference

12 December 2020

Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics

1 reference

12 December 2020

Unitary versus multidimensional models of alcoholism treatment outcome: an empirical study

1 reference

12 December 2020

10.1097/JCP.0B013E3180CA86E5

Identifiers

DOI

1 reference

7 August 2017

1 reference

7 August 2017

1 reference